Bank of New York Mellon
TARO

Bank of New York Mellon’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Bank of New York Mellon’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-22,436
Closed -$950K – 4310
2024
Q1 		$950K Sell
22,436
-155
-0.7% -$6.53K ﹤0.01% 3180
2023
Q4 		$944K Buy
22,591
+368
+2% +$13.6K ﹤0.01% 3213
2023
Q3 		$838K Buy
22,223
+307
+1% +$11.5K ﹤0.01% 3263
2023
Q2 		$831K Buy
+21,916
New +$688K ﹤0.01% 3312
2021
Q3 		– Sell
-10,782
Closed -$776K – 4572
2021
Q2 		$776K Sell
10,782
-378
-3% -$27.8K ﹤0.01% 3564
2021
Q1 		$823K Sell
11,160
-6,903
-38% -$524K ﹤0.01% 3444
2020
Q4 		$1.33M Buy
18,063
+2,342
+15% +$151K ﹤0.01% 3088
2020
Q3 		$862K Sell
15,721
-18,714
-54% -$1.16M ﹤0.01% 3211
2020
Q2 		$2.29M Sell
34,435
-761
-2% -$51K ﹤0.01% 2600
2020
Q1 		$2.15M Sell
35,196
-22,273
-39% -$1.65M ﹤0.01% 2510
2019
Q4 		$5.05M Buy
57,469
+9,019
+19% +$761K ﹤0.01% 2341
2019
Q3 		$3.66M Sell
48,450
-1,459
-3% -$118K ﹤0.01% 2433
2019
Q2 		$4.26M Buy
49,909
+3,108
+7% +$307K ﹤0.01% 2411
2019
Q1 		$5.06M Sell
46,801
-10,415
-18% -$1.04M ﹤0.01% 2327
2018
Q4 		$4.84M Buy
57,216
+26,540
+87% +$2.56M ﹤0.01% 2314
2018
Q3 		$3.02M Buy
30,676
+10,567
+53% +$1.14M ﹤0.01% 2635
2018
Q2 		$2.33M Buy
20,109
+8,492
+73% +$933K ﹤0.01% 2772
2018
Q1 		$1.15M Buy
11,617
+5,694
+96% +$577K ﹤0.01% 3138
2017
Q4 		$620K Sell
5,923
-24,579
-81% -$2.7M ﹤0.01% 3515
2017
Q3 		$3.44M Buy
30,502
+436
+1% +$47.4K ﹤0.01% 2522
2017
Q2 		$3.37M Sell
30,066
-4,611
-13% -$521K ﹤0.01% 2535
2017
Q1 		$4.04M Buy
34,677
+538
+2% +$59.5K ﹤0.01% 2429
2016
Q4 		$3.59M Sell
34,139
-500
-1% -$52.4K ﹤0.01% 2511
2016
Q3 		$3.83M Buy
34,639
+1,506
+5% +$199K ﹤0.01% 2370
2016
Q2 		$4.82M Buy
33,133
+15,623
+89% +$2.22M ﹤0.01% 2228
2016
Q1 		$2.51M Buy
17,510
+619
+4% +$87.9K ﹤0.01% 2532
2015
Q4 		$2.61M Buy
16,891
+15,217
+909% +$2.22M ﹤0.01% 2559
2015
Q3 		$239K Buy
1,674
+213
+15% +$29.8K ﹤0.01% 3844
2015
Q2 		$210K Sell
1,461
-8,885
-86% -$1.27M ﹤0.01% 3875
2015
Q1 		$1.46M Buy
10,346
+1,916
+23% +$295K ﹤0.01% 3077
2014
Q4 		$1.25M Buy
8,430
+1
+0% +$147 ﹤0.01% 3162
2014
Q3 		$1.3M Hold
8,429
– – ﹤0.01% 3143
2014
Q2 		$1.18M Hold
8,429
– – ﹤0.01% 3217
2014
Q1 		$936K Buy
+8,429
New +$918K ﹤0.01% 3318

Other funds holding TARO

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
AIIMS
Analyst IMS Investment Management Services Tel-Aviv, Israel $4.3B AUM 37.33% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
LI
LRI Investments Palm Beach Gardens, Florida $1.24B AUM 11.13% 1-Year Est. Return
GCM
Gladius Capital Management Chicago, Illinois $1.65B AUM 25.75% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Bank of New York Mellon's TARO Position: Q2 2024 in Review

Bank of New York Mellon sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2024, closing a stake of 22,436 shares — an estimated $950K sold.

Bank of New York Mellon first reported a position in TARO in Q1 2014 and held it in 34 quarters. The position peaked at $5.06M in Q1 2019. 16 funds tracked by Wall St. Rank hold TARO as of Q2 2024.

  • Bank of New York Mellon reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2024 after selling out during the quarter.
  • Bank of New York Mellon sold 22,436 Taro Pharmaceutical Industries Ltd. shares in Q2 2024, an estimated $950K.
  • Bank of New York Mellon first reported a position in Taro Pharmaceutical Industries Ltd. in Q1 2014 and held it in 34 quarters.
  • Bank of New York Mellon's Taro Pharmaceutical Industries Ltd. position peaked at $5.06M in Q1 2019.
  • 16 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2024.

Based on Bank of New York Mellon's 13F filing for Q2 2024, filed 25 Jul 2024.